Evidence map›Paper›PMID 29510755›Full record

ArticleBMC medical genomics2018

Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Alain Calender, Pierre Antoine Rollat Farnier, Adrien Buisson, Stéphane Pinson, Abderrazzaq Bentaher, Serge Lebecque, Harriet Corvol, Rola Abou Taam, Véronique Houdouin, Claire Bardel and 12 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02829853 (Clinical and Genetic Study of Familial Sarcoidosis), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02829853 unknown statusnot on this map

Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)

TypeobservationalSponsorHospices Civils de LyonRan2008 to 2016Enrolled800ConditionsSarcoidosisArmsGenetic analysis by SANGER and WHOLE EXOME NEXT GENERATION SEQUENCING
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 4 countries.

Alain CalenderGenetics Department, Hospices Civils de LYON (HCL), University Hospital, East Pathology Center, LYON, B-A3, 59 Bld Pinel, 69677, BRON Cedex, France. alain.calender@chu-lyon.fr.ORCID 0000-0001-8063-4932
Pierre Antoine Rollat FarnierDepartment of biostatistics, University Hospital, Hospices Civils de LYON (HCL), Lyon, France.
Adrien BuissonGenetics Department, Hospices Civils de LYON (HCL), University Hospital, East Pathology Center, LYON, B-A3, 59 Bld Pinel, 69677, BRON Cedex, France.
Stéphane PinsonGenetics Department, Hospices Civils de LYON (HCL), University Hospital, East Pathology Center, LYON, B-A3, 59 Bld Pinel, 69677, BRON Cedex, France.
Abderrazzaq BentaherInflammation & Immunity of the Respiratory Epithelium - EA7426 (PI3) - South Medical University Hospital - Lyon 1 Claude Bernard University, 165 Chemin du Grand Revoyet, 69310, Pierre-Bénite, France.
Serge LebecqueCancer Research Center, INSERM U-1052, CNRS 5286, 69008, Lyon, France.
Harriet CorvolPediatric pulmonology and Reference Center for rare lung diseases RespiRare, Hôpital Trousseau, AP-HP, INSERM UMR-S938, Sorbonne University, Paris, France.
Rola Abou TaamPediatric pulmonology and Reference Center for rare lung diseases RespiRare, Hôpital Necker, Paris, France.
Véronique HoudouinPediatric pulmonology and Reference Center for rare lung diseases RespiRare, Hôpital Robert Debré, INSERM U-1142, University Paris Diderot VII, Paris, France.
Claire BardelDepartment of biostatistics, University Hospital, Hospices Civils de LYON (HCL), Lyon, France.
Pascal RoyDepartment of biostatistics, University Hospital, Hospices Civils de LYON (HCL), Lyon, France.
Gilles DevouassouxDepartment of Pulmonology, University Hospital, Hôpital Croix Rousse, Lyon, France.
Vincent CottinDepartment of Pulmonology, University Hospital, Hôpital Louis Pradel, Lyon, France.
Pascal SeveDepartment of Internal medicine, University Hospital, Hôpital Croix Rousse, Lyon, France.
Jean-François BernaudinHistology and Tumor Biology, ER2 UPMC, Hôpital Tenon, Paris, France.
Clarice X LimMedical University of Vienna, Center for Pathobiochemistry and Genetics, Institute of Medical Genetics, Währinger Straße 10, 1090, Vienna, Austria.
Thomas WeichhartMedical University of Vienna, Center for Pathobiochemistry and Genetics, Institute of Medical Genetics, Währinger Straße 10, 1090, Vienna, Austria.
Dominique ValeyreEA2363, University Paris 13, COMUE Sorbonne-Paris-Cité, 74 rue Marcel Cachin, 93009, Bobigny, France.
Yves PachecoInflammation & Immunity of the Respiratory Epithelium - EA7426 (PI3) - South Medical University Hospital - Lyon 1 Claude Bernard University, 165 Chemin du Grand Revoyet, 69310, Pierre-Bénite, France.
Annick ClementAP-HP Pediatric pulmonology and Reference Center for rare lung diseases RespiRare, Hôpital Trousseau, INSERM UMR-S933, Sorbonne University, Paris, France.
Nadia NathanAP-HP Pediatric pulmonology and Reference Center for rare lung diseases RespiRare, Hôpital Trousseau, INSERM UMR-S933, Sorbonne University, Paris, France.
in the frame of GSF (Groupe Sarcoïdose France)
Université Claude Bernard Lyon 1 · FRHôpital de la Croix-Rousse · FRHospices Civils de Lyon · FRInserm · FRHôpital Necker-Enfants Malades · FRSorbonne Université · FRCentre National de la Recherche Scientifique · FRMedical University of Vienna · ATUniversité Sorbonne Paris Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcoidosis (OMIM 181000) is a multi-systemic granulomatous disorder of unknown origin. Despite multiple genome-wide association (GWAS) studies, no major pathogenic pathways have been identified to date. To find out relevant sarcoidosis predisposing genes, we searched for de novo and recessive mutations in 3 young probands with sarcoidosis and their healthy parents using a whole-exome sequencing (WES) methodology.

methodsFrom the SARCFAM project based on a national network collecting familial cases of sarcoidosis, we selected three families (trios) in which a child, despite healthy parents, develop the disease before age 15 yr. Each trio was genotyped by WES (Illumina HiSEQ 2500) and we selected the gene variants segregating as 1) new mutations only occurring in affected children and 2) as recessive traits transmitted from each parents. The identified coding variants were compared between the three families. Allelic frequencies and in silico functional results were analyzed using ExAC, SIFT and Polyphenv2 databases. The clinical and genetic studies were registered by the ClinicalTrials.gov - Protocol Registration and Results System (PRS) ( https://clinicaltrials.gov ) receipt under the reference NCT02829853 and has been approved by the ethical committee (CPP LYON SUD EST - 2 - REF IRB 00009118 - September 21, 2016).

resultsWe identified 37 genes sharing coding variants occurring either as recessive mutations in at least 2 trios or de novo mutations in one of the three affected children. The genes were classified according to their potential roles in immunity related pathways: 9 to autophagy and intracellular trafficking, 6 to G-proteins regulation, 4 to T-cell activation, 4 to cell cycle and immune synapse, 2 to innate immunity. Ten of the 37 genes were studied in a bibliographic way to evaluate the functional link with sarcoidosis.

conclusionsWhole exome analysis of case-parent trios is useful for the identification of genes predisposing to complex genetic diseases as sarcoidosis. Our data identified 37 genes that could be putatively linked to a pediatric form of sarcoidosis in three trios. Our in-depth focus on 10 of these 37 genes may suggest that the formation of the characteristic lesion in sarcoidosis, granuloma, results from combined deficits in autophagy and intracellular trafficking (ex: Sec16A, AP5B1 and RREB1), G-proteins regulation (ex: OBSCN, CTTND2 and DNAH11), T-cell activation (ex: IDO2, IGSF3), mitosis and/or immune synapse (ex: SPICE1 and KNL1). The significance of these findings needs to be confirmed by functional tests on selected gene variants.

Indexed as

Exome SequencingPedigreeBase SequenceChildFemaleGenetic VariationGenome-Wide Association StudyHumansMaleSarcoidosisCandidate genesSarcoidosisWhole-exome sequencing (WES)

Identifiers

PMID29510755
PMCPMC5839022
OpenAlexW2801779162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.